These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 31301176

  • 1. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J, Paz Y Miño F, Borobio V, Badenas C, Rodriguez-Revenga L, Pauta M, Borrell A.
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [Abstract] [Full Text] [Related]

  • 2. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P, Chitayat D, Roifman M, Wasim S, Carmona S, Ryan G, Noor A, Kolomietz E, Chong K.
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [Abstract] [Full Text] [Related]

  • 3. Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT.
    Gadsbøll K, Vogel I, Kristensen SE, Pedersen LH, Hyett J, Petersen OB, Danish Cytogenetic Central Register study group.
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):470-479. PubMed ID: 38642365
    [Abstract] [Full Text] [Related]

  • 4. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
    Lindquist A, Hui L, Poulton A, Kluckow E, Hutchinson B, Pertile MD, Bonacquisto L, Gugasyan L, Kulkarni A, Harraway J, Howden A, McCoy R, Da Silva Costa F, Menezes M, Palma-Dias R, Nisbet D, Martin N, Bethune M, Poulakis Z, Halliday J.
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
    [Abstract] [Full Text] [Related]

  • 5. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR, Zhang Y, Ru T, Li J, Yang L, Xu Y, Duan HL, Wang Y, Wang Y, Hu YL, Zhang Y, Zheng MM.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb 25; 55(2):94-99. PubMed ID: 32146737
    [Abstract] [Full Text] [Related]

  • 6. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB, Rode L, Ekelund CK, Sundberg K, Kjaergaard S, Zingenberg H, Tabor A.
    Ultrasound Obstet Gynecol; 2018 Apr 25; 51(4):470-479. PubMed ID: 28640470
    [Abstract] [Full Text] [Related]

  • 7. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
    Huang LY, Pan M, Han J, Zhen L, Yang X, Li DZ.
    J Obstet Gynaecol; 2018 May 25; 38(4):498-501. PubMed ID: 29433355
    [Abstract] [Full Text] [Related]

  • 8. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
    Hui L, Pynaker C, Bonacquisto L, Lindquist A, Poulton A, Kluckow E, Hutchinson B, Norris F, Pertile MD, Gugasyan L, Kulkarni A, Harraway J, Howden A, McCoy R, da Silva Costa F, Menezes M, Palma-Dias R, Nisbet D, Martin N, Bethune M, Poulakis Z, Halliday J.
    Am J Obstet Gynecol; 2021 Nov 25; 225(5):527.e1-527.e12. PubMed ID: 33957116
    [Abstract] [Full Text] [Related]

  • 9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D, Langlois S, Douglas Wilson R, SOGC GENETICS COMMITTEE, CCMG PRENATAL DIAGNOSIS COMMITTEE.
    J Obstet Gynaecol Can; 2011 Jul 25; 33(7):736-750. PubMed ID: 21749752
    [Abstract] [Full Text] [Related]

  • 10. Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study.
    Bet BB, Lugthart MA, Linskens IH, van Maarle MC, van Leeuwen E, Pajkrt E.
    Ultrasound Obstet Gynecol; 2024 Aug 25; 64(2):164-172. PubMed ID: 38411313
    [Abstract] [Full Text] [Related]

  • 11. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P, Sonek J, Hoopmann M, Abele H, Kagan KO.
    Ultrasound Obstet Gynecol; 2016 Oct 25; 48(4):446-451. PubMed ID: 26611869
    [Abstract] [Full Text] [Related]

  • 12. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
    Kagan KO, Sroka F, Sonek J, Abele H, Lüthgens K, Schmid M, Wagner P, Brucker S, Wallwiener D, Hoopmann M.
    Ultrasound Obstet Gynecol; 2018 Apr 25; 51(4):437-444. PubMed ID: 28925570
    [Abstract] [Full Text] [Related]

  • 13. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
    Pan M, Han J, Zhen L, Yang X, Li R, Liao C, Li DZ.
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb 25; 197():164-7. PubMed ID: 26771907
    [Abstract] [Full Text] [Related]

  • 14. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
    Leung TY, Vogel I, Lau TK, Chong W, Hyett JA, Petersen OB, Choy KW.
    Ultrasound Obstet Gynecol; 2011 Sep 25; 38(3):314-9. PubMed ID: 21400624
    [Abstract] [Full Text] [Related]

  • 15. Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy.
    Cimpoca B, Syngelaki A, Litwinska E, Muzaferovic A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2020 Mar 25; 55(3):318-325. PubMed ID: 31773823
    [Abstract] [Full Text] [Related]

  • 16. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z.
    Srp Arh Celok Lek; 2012 Mar 25; 140(9-10):606-11. PubMed ID: 23289277
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA, Bakker M, Bardi F, Fontanella F, Bakker MK, Fleurke-Rozema JH, Bilardo CM.
    Ultrasound Obstet Gynecol; 2018 Apr 25; 51(4):463-469. PubMed ID: 28397377
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
    Minnella GP, Crupano FM, Syngelaki A, Zidere V, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2020 May 25; 55(5):637-644. PubMed ID: 31875326
    [Abstract] [Full Text] [Related]

  • 19. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F, Gagnon A, Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada, Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists.
    J Obstet Gynaecol Can; 2011 Jul 25; 33(7):754-67. PubMed ID: 21749753
    [Abstract] [Full Text] [Related]

  • 20. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
    Bardi F, Bosschieter P, Verheij J, Go A, Haak M, Bekker M, Sikkel E, Coumans A, Pajkrt E, Bilardo C.
    Prenat Diagn; 2020 Jan 25; 40(2):197-205. PubMed ID: 31697852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.